Our Committees
For IDA, committees serve as both governance bodies and collaborative fora where members can address a wide range of operational, strategic, and thematic areas. These committees will facilitate knowledge sharing, networking, and collaborative initiatives, making them valuable for both IDA and its members. IDA will have two types of committees: disease area-specific committees and cross-cutting committees. These committees will help guide IDA’s work in key focus areas:
Specialized Committees
These committees will focus on particular infectious disease areas, helping to develop targeted advocacy and policy strategies, as well as serve as a space for exchange and collaboration. Each committee will have experts from relevant fields and will work on specific issues such as:
-
Vaccine-Preventable Diseases
-
Antimicrobial Resistance (AMR)
-
HIV/AIDS and Sexually Transmitted Infections (STIs)
-
Respiratory Infections
-
Vector-Borne Diseases
-
Zoonotic Diseases
-
Emerging Infectious Diseases
-
One Health
-
Neglected Tropical Diseases (NTDs)
-
Integrated primary health-care
Advocacy and Policy Committee
The committee aims at planning advocacy activities for IDA, coordinate advocacy efforts across the membership, ensuring a unified voice on key infectious disease issues. It serves as a space for members to share insights, strategies, and opportunities for joint advocacy.
Members have an opportunity to work together on global campaigns, policy statements, and strategies to influence governments and international institutions such as the WHO, UNEP, and UN.
Research and Innovation
Promotes research and innovation that explores the interdependence of human, animal, and plant health, fostering collaborations that address challenges like zoonotic diseases and antimicrobial resistance. The committee will also identify gaps in research and advocate for funding and attention.
The committee is also a collaborative where members present ongoing studies, brainstorm joint research proposals, and share innovative solutions to infectious disease challenges.
Infectious Disease Emergency Management Committee
The purpose of the this committee is to foster collaboration between civil society organizations, WHO, governments, and healthcare systems, ensuring rapid and effective responses to infectious disease outbreaks. The committee is dedicated to strengthening emergency management preparedness, enhancing the capacity of civil society organizations, and coordinating comprehensive response strategies. It also focuses on developing well-structured plans for swift coordination during health crises to mitigate their impact.
Partnerships and Stakeholder Engagement Committee
The committee manages and fosters strategic relationships between IDA and external partners, including the private sector, international organizations, and governments. The committee also helps members navigate these partnerships.
Members use this space to discuss potential partnership opportunities, develop joint projects, and exchange strategies for engaging key stakeholders.
Digital Health and Technology Committee
The committee aims at exploring how digital tools, data analytics, and technology can support infectious disease prevention and control. This committee serves as a highly relevant space for knowledge exchange on innovations in health tech, data systems, and digital health platforms.
Members share among each other tech solutions, partner on pilot projects, and explore digital platforms for disease surveillance, diagnostics, and health education.
Supporter's group
The Infectious Disease Alliance (IDA) Supporters Group is a network of funders and strategic partners dedicated to addressing infectious diseases on the global health agenda. Meeting regularly, the group provides a platform for dialogue on pressing global health issues, fosters partnerships, and drives joint advocacy efforts.
​
By uniting key players across sectors, the Supporters Group leverages collective expertise and resources to shape policy and promote sustainable solutions for combating infectious diseases. Through its collaborative approach, the group plays a vital role in ensuring a coordinated response to the global infectious disease challenge.
